Trial Profile
A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associated with Parkinson's disease with depression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2019
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Pain
- Focus Therapeutic Use
- 22 Apr 2019 Status changed from recruiting to completed.
- 27 Sep 2017 Planned number of patients changed from 40 to 50.
- 08 Aug 2017 Planned number of patients changed from 100 to 40.